Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective

Chlamydia trachomatis infection in the family planning clinical setting across New South Wales

Deborah J. Bateson A C , Edith Weisberg A and Harpreet Lota B

A Sydney Centre for Reproductive Health Research, FPA Health, 328–336 Liverpool Rd, Ashfield, NSW 2131, Australia.

B Imperial College London, SAF Building, Exhibition Road, South Kensington SW7 2AZ, UK.

C Corresponding author. Email:

Sexual Health 3(1) 15-20
Submitted: 17 March 2005  Accepted: 13 December 2005   Published: 20 February 2006


Background: Following a small pilot study in 2003, a study was set up to determine the prevalence of genital Chlamydia trachomatis infection in young women presenting to Family Planning NSW centres across New South Wales and to evaluate the characteristics of those infected. Methods: A cross-sectional survey of 621 consecutive women aged from 16 to 24 years was carried out over a 3-month period in 2004 at five Family Planning NSW centres. Urine samples were tested for C. trachomatis using the polymerase chain reaction (PCR) method. Women with a positive result were reviewed and treated. Results: Of 925 eligible clients, 621 (67%) were recruited to the study. Chlamydia trachomatis was detected in 35 of the 621 recruits (5.6%, 95% CI 3.8–7.4). The prevalence at the Hunter centre was significantly higher than the combined prevalence at the other four participating centres (9.7% compared with 3.9%; P = 0.008). Two characteristics were identified as independent predictors of infection in this study: ‘reporting a recent change of partner in the past three months’ (crude odds ratio (OR) 3.33, 95% CI 1.67–6.64) and ‘reporting three or more partners in the past year’ (crude OR 3.69, 95% CI 1.83–7.46). Reported condom use, a history of one or more sexually transmissible infections and current combined oral contraceptive pill use were not associated with infection in this study. Conclusions: The prevalence of C. trachomatis infection is sufficiently high to support targeted testing of 16–24-year-old women in the Family Planning NSW setting and informs the development of a national screening strategy.


[1]  Yohannes K Roche P Blumer C Spencer J Milton A Bunn C et al 2004 Australia’s notifiable disease status, 2002: annual report of the National Notifiable Diseases Surveillance System. Comm Dis Int 28 6 68

[2]  Year in review: communicable disease. N S W Public Health Bull 2004; 15(9–10): 157–67.

[3]  Williams H Tabrizi SN Lee W Kovacs GT Garland S 2003 Adolescence and other risk factors for Chlamydia trachomatis genitourinary infection in women in Melbourne, Australia. Sex Transm Infect 79 31 4
doi:10.1136/sti.79.1.31 Pubmed Abstract

[4]  Heal C Jones B Veitch C Lamb S Hodgens S Browning S et al 2002 Screening for Chlamydia in general practice. Austr Family Physician 31 779 82

[5]  Bateson DJ . The Chlamydia Prevalence Pilot Study. FPA Health. 2004. Requests to author.

[6]  Cotterell L , Mercier N , Foran T . Chlamydia: who’s at risk? In: Dayan L, editor. 2001 – a sex odyssey. Proceedings of the Australasian Sexual Health Conference, Sydney, 2–5 May 2001. Sydney: Australasian College of Sexual Health Physicians; 2001. p. 19.

[7]  Cole R , Jasiak S , Thomas S , McPherson A. , Stellingwerff M , Critchley A. Chlamydia Audit 2001, The Warehouse Youth Health Centre, FPA Health, internal document (requests to author).

[8]  Stamm W . Chlamydia trachomatis infections of the adult. In: Holmes KK, Sparling PF, Mardah PA, Weisner PJ, editors. Sexually transmitted diseases. 3rd edn. New York: McGraw Hill; 1999. pp. 409–18.

[9]  Simms I Stephenson JM 2000 Pelvic inflammatory disease epidemiology: what do we know and what do we need to know? Sex Transm Infect 76 80 7
doi:10.1136/sti.76.2.80 Pubmed Abstract

[10]  Fleming DT Wasserheit JN 1999 From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75 3 17 Pubmed Abstract

[11]  Centers for Disease Control and Prevention 2002 Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoea infections – 2002. Morb Mortal Weekly Rep 51 1 27

[12]  Garrow SC Smith DW Hartnett GB 2002 The diagnosis of Chlamydia, gonorrhoea and trichomonas infections by self obtained low vaginal swabs, in remote northern Australian clinical practice. Sex Transm Infect 78 278 81
doi:10.1136/sti.78.4.278 Pubmed Abstract

[13]  Chen MY Donovan B 2004 Genital Chlamydia trachomatis infection in Australia: epidemiology and clinical implications. Sex Health 1 189 96 doi:10.1071/SH04027

[14]  Hocking J , Willlis J , Tabrizi S , Hellard M , Jolley D , Garland S , et al Chlamydia risk factor and prevalence survey of young women aged 18–35 living in Victoria. In: Waddell R, editor. Proceedings of the Australasian Sexual Health Conference, Adelaide, 31 March–3 April 2004. Adelaide: Australasian College of Sexual Health Physicians; 2004. p. 20.

[15]  Hunter Public Health Unit. State of Health in the Hunter. Hunter Area Health Service: 2003. [verified February 2006].

[16]  Gaydos CA Howell MR Pare B 1998 Chlamydia trachomatis infections in female military recruits. N Engl J Med 339 739 44 doi:10.1056/NEJM199809103391105 Pubmed Abstract

[17]  Turner CF Rogers SM Miller HG Miller WC Gribble JN Chromy JR et al 2002 Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA 287 726 33 doi:10.1001/jama.287.6.726 Pubmed Abstract

[18]  Marrazzo JM White CL Krekeler B Ceclum CL Lafferty WE Stamm WE et al 1997 Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 127 796 803 Pubmed Abstract

[19]  Fenton KA Korovessis C Johnson AM McCadden A McManus S Wellings K et al 2001 Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genial Chlamydia trachomatis infection. Lancet 358 1851 3 doi:10.1016/S0140-6736(01)06886-6 Pubmed Abstract

[20]  Westom L 1975 The effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 121 707 13 Pubmed Abstract

[21]  Louv WC Austin H Perlman J Alexander WJ 1989 Oral contraceptive use and the risk of chlamydial and gonococcal infection. Am J Obstet Gynecol 160 396 402

[22]  Baeten JM Nyange PM Richardson BA Lavreys L Chohan B Martin HL Jr et al 2001 Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 185 380 5
doi:10.1067/mob.2001.115862 Pubmed Abstract

[23]  Morrison CS Bright P Wong EL Kwok C Yacobsen I Gaydos CA et al 2004 Hormonal contraceptive use, cervical ectopy and the acquisition of cervical infections. Sex Transm Dis 31 561 7 Pubmed Abstract

Export Citation